BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22891340)

  • 21. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia.
    Wolff NC; Vega-Rubin-de-Celis S; Xie XJ; Castrillon DH; Kabbani W; Brugarolas J
    Mol Cell Biol; 2011 May; 31(9):1870-84. PubMed ID: 21383064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction.
    Allen A; Zheng Y; Gardner L; Safford M; Horton MR; Powell JD
    J Immunol; 2004 Apr; 172(8):4797-803. PubMed ID: 15067056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs.
    Shrestha S; Yang K; Wei J; Karmaus PW; Neale G; Chi H
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14858-63. PubMed ID: 25271321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.
    Lin JT; Lineberry NB; Kattah MG; Su LL; Utz PJ; Fathman CG; Wu L
    J Immunol; 2009 May; 182(10):5919-28. PubMed ID: 19414743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD28 and CTLA-4 coreceptor expression and signal transduction.
    Rudd CE; Taylor A; Schneider H
    Immunol Rev; 2009 May; 229(1):12-26. PubMed ID: 19426212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance.
    Hegazy AM; Yamada D; Kobayashi M; Kohno S; Ueno M; Ali MA; Ohta K; Tadokoro Y; Ino Y; Todo T; Soga T; Takahashi C; Hirao A
    J Biol Chem; 2016 Oct; 291(41):21496-21509. PubMed ID: 27519418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells.
    Wang Y; Huang G; Zeng H; Yang K; Lamb RF; Chi H
    Proc Natl Acad Sci U S A; 2013 Dec; 110(50):E4894-903. PubMed ID: 24282297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTOR at the crossroads of T cell proliferation and tolerance.
    Mondino A; Mueller DL
    Semin Immunol; 2007 Jun; 19(3):162-72. PubMed ID: 17383196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway.
    Zhang HH; Huang J; Düvel K; Boback B; Wu S; Squillace RM; Wu CL; Manning BD
    PLoS One; 2009 Jul; 4(7):e6189. PubMed ID: 19593385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of mast cell survival and function by tuberous sclerosis complex 1.
    Shin J; Pan H; Zhong XP
    Blood; 2012 Apr; 119(14):3306-14. PubMed ID: 22362037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular regulation of T-cell anergy.
    Zheng Y; Zha Y; Gajewski TF
    EMBO Rep; 2008 Jan; 9(1):50-5. PubMed ID: 18174897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.
    Dibble CC; Elis W; Menon S; Qin W; Klekota J; Asara JM; Finan PM; Kwiatkowski DJ; Murphy LO; Manning BD
    Mol Cell; 2012 Aug; 47(4):535-46. PubMed ID: 22795129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal anergy is maintained independently of T cell proliferation.
    Colombetti S; Benigni F; Basso V; Mondino A
    J Immunol; 2002 Dec; 169(11):6178-86. PubMed ID: 12444122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice.
    Kladney RD; Cardiff RD; Kwiatkowski DJ; Chiang GG; Weber JD; Arbeit JM; Lu ZH
    Cancer Res; 2010 Nov; 70(21):8937-47. PubMed ID: 20940396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TSC1 controls IL-1β expression in macrophages via mTORC1-dependent C/EBPβ pathway.
    Yang T; Zhu L; Zhai Y; Zhao Q; Peng J; Zhang H; Yang Z; Zhang L; Ding W; Zhao Y
    Cell Mol Immunol; 2016 Sep; 13(5):640-50. PubMed ID: 27593484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained activation of mTORC1 in macrophages increases AMPKα-dependent autophagy to maintain cellular homeostasis.
    Pan H; Zhong XP; Lee S
    BMC Biochem; 2016 Jul; 17(1):14. PubMed ID: 27387347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity.
    Liang MC; Ma J; Chen L; Kozlowski P; Qin W; Li D; Goto J; Shimamura T; Hayes DN; Meyerson M; Kwiatkowski DJ; Wong KK
    Oncogene; 2010 Mar; 29(11):1588-97. PubMed ID: 19966866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.
    Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS
    PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-specific ablation of Tsc1 in pancreatic beta-cells.
    Mori H; Guan KL
    Methods Mol Biol; 2012; 821():407-19. PubMed ID: 22125081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditions of limited calcium influx (CLCI) inhibits IL2 induction and favors expression of anergy-related genes in TCR/CD3 and CD28 costimulated primary human T cells.
    Monaco S; Jahraus B; Samstag Y; Bading H
    Mol Immunol; 2019 Oct; 114():81-87. PubMed ID: 31344552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.